Normativa sobre diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica

Archivos de Bronconeumologia

Volumn 32, Issue 6, 1996, Pages 285-301

  Montemayor, T ^a   Alfajeme, I ^b   Escudero, C ^c   Morera, J ^d   Sanchez Agudo L ^e  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHITIS; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; LUNG EMPHYSEMA; MEDICAL SOCIETY; PRACTICE GUIDELINE; PULMONOLOGY; REVIEW; SPAIN; THORAX SURGERY;

BRONCHITIS; CHRONIC DISEASE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; PULMONARY DISEASE (SPECIALTY); PULMONARY EMPHYSEMA; SOCIETIES, MEDICAL; SPAIN; THORACIC SURGERY;

EID: 0030162529     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-2896(15)30754-7     Document Type: Article

References (185)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructie pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
2. National Heart, Lung, and Blood Institute, Division of Lung Diseases Worshop Report. The definition of emphysema. Am Rev Respir Dis 1985; 132: 182-185.
3. Ciba Guest Symposium Report. Terminology, definitions of chronic pulmonary emphysema and related conditions. Thorax 1959; 14: 286-299.
4. Ramsdell JW, Nachtemy FJ, Moser KM. Bronchial hyperreactivity in chronic obstructive bronchitis. Am Rev Respir Dis 1982; 126: 829-832.
5. Thurlbeck WM. Chronic airflow obstruction. En: Thurlbeck WM, editor. Pathology of the lung. Nueva York, Thieme: Medical Publishers Inc., 1988; 519-575.
6. US Department of Health and Human Services Chronic Obstructive Lung Disease. The health consequences of smoking. A report of the surgeon General Rockville. Government Printing Office, 1984. Public Health Service Publication n.o 84-50205.
7. Linden M, Rasmussen JB, Piiyulainen E et al. Airwau inflammation in smokers with nonobstructive and obstructive chronic bronchitis. Am Rev Respir Dis 1993; 148: 1.226-1.232.
8. Saetta M, Di Stefano A, Maestrelli P et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care 1994; 150: 1.646-1.650.
9. Thurlbeck WM. Pathophysiology of chronic obstructive pulmonary disease. Clin Chest Med 1990; 11: 389-403.
10. Thurbeck WM. Pathophysiology of chronic airflow obstruction. Chest 1990; 97: 6-10.
11. Anthonisen RR, Bass H, Oriol A et al. Regional lung fuction in patients with chronic bronchitis. Clin Sci 1968; 35:494.
12. Hogg AF, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278: 1.355-1.360.
13. McCarthy DS, Spencer R, Greene R et al. Measurement of closing volume as a simple and sensitive test for early detection of small airway disease. Am J Med 1972; 52: 742.
14. Buist AS, Ross BB. Quantitative analysis of the alveolar plateau in the diagnosis of early airway obstruction. Am Rev Respir Dis 1973; 103: 1.078.
15. McFadden ER Jr, Linden DA. A reduction in maximal mid-expiratory fow rate, a spirographic manifestation of small airway disease. Am J Med 1972; 52: 725.
16. Woolcok AJ, Vincent NJ, Macklem PT. Frequency dependence of compliance as test for obstruction in the small airways. J Clin Invest 1969; 48: 1.097.
17. Stanescu DC, Rodenstein DO, Hoenen C et al. Sensitive tests are poor predictors of the decline in forced expiratory volume in one second in middle aged smokers. Am Rev Respir Dis 1987; 135: 585-590.
18. Buist AS, Vollmer WM, Johnson LR et al. Does the single-breath N2 test identify the smokers who will develop chronic airflow limitation? Am Rev Respir Dis 1988; 137: 293-301.
19. Saetta M, Izquierdo JL, Kim WD et al. Centrilobular and panacinar emphysema in smokers. Two different diseases. Am Rev Respir Dis 1990; 141: 713.
20. Cosio MG, Chezzo H, Hogg JC et al. The relation between structural changes in small airways and pulmonary fuction tests. N Engl J Med 1978; 298: 1.277-1.281.
21. Mitchell RS, Stanford RE, Johnson JM et al. The morphologic features of the bronchi, bronchioles, and alveoli in chronic obstruction. A clinicopathologic study. Am Rev Respir Dis 1976; 114: 137-145.
22. Nagai A, West WW, Thurlbeck WM. National Institutes of Health intermittent positive-pressure breathing trial: pathology studies II. Correlation between morphologic finginds, clinical finginds, and evidence of expiratory airflow obstruction. Am Rev Respir Dis 1985; 132: 946-953.
23. Anthonisem NR, Manfreda I, Warren CPW. Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
24. Badgett RG, Tamaka DJ, Hunt DK et al. Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone? Am J Med 1993; 94: 188-196.
25. Burki NK. Roentgenologic diagnosis of emphysema. Chest 1989; 95: 1.178-1.179.
26. Pratt PC. Role of conventional chest radiography in diagnosis and exclusion of emphysema. Am J Med 1987; 82: 998-1.006.
27. Chetty KG, Brown SE, Light RW. Identification of pulmonary hypertension in chronic obstructive pulmonary disease from routine chest radiographs. Am Rev Respir Dis 1982; 126: 338-341.
28. Thurlbeck WM, Simon G. Radiographic appearance of the chest in emphysema. Am J Roentgenol 1978; 130: 429-440.
29. Nicklaus TM, Stomell DW, Christiansen WR et al. The accuracy of roent-genologic diagnosis of chronic pulmonary emphysema. Am Rev Respir Dis 1966; 93: 889-899.
30. Bergin CJ, Muller NL, Miller RR. CT in the quantitative assessment of emphysema. J Thorac Imaging 1986; 1: 94-103.
31. Foster WL Jr, Pratt PC, Roggli VL et al. Centrilobular emphysema. CT pathogenic correlation. Radiology 1986; 159: 27-32.
32. Miller RR, Muller RL, Vedal S et al. Limitations of computed tomography in the assessment of emphysema. Am Rev Respir Dis 1989; 139: 980-983.
33. Kumano K, Matsuba K, Ikeda T et al. The diagnosis of mild emphysema. Correlation of computed tomography and pathology scores. Am Rev Respir Dis 1990; 141: 169-178.
34. Kinsella MK, Muller NL, Abboud RT et al. Quantitation of emphysema by computed tomography using a density mask program and correlation with pulmonary function tests. Chest 1990; 97: 315-321.
35. American Thoracic Society. Standardization of spirometric. Am Rev Respir Dis 1987; 136: 1.285-1.298.
36. Sociedad Española de Patología Respiratoria (SEPAR). Normativa para la espirometría forzada. Barcelona: Ed. Doyma, 1985.
37. Quanjer PH, Tammeling GJ, Cotes JE et al. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6: 5-40.
38. a ed.). Filadelfia: W.B. Saunders, 1971.
39. Carter R, Nicotra B, Blevins W et al. Altered exercise gas exchange and cardiac function in patients with mild chronic obstructive pulmonary disease. Chest 1993; 103: 745-750.
40. Weisman IM, Zeballos RJ. Clinical excercise testing. Clin Chest Med 1994; 15: 2.
41. American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 1986; 133: 1.205.
42. Cotes JE. Rating respiratory disability: a report on behalf of a working group of the European Society for clinical respiratory physiology. Eur Respir J 1990; 3: 1.074.
43. Ortega F, Montemayor T, Sánchez A et al. Role of cardiopulmonary exercise testing and the criteria used to determine disability in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150: 747-751.
44. Montemayor T. Oxigenoterapia en esfuerzo en la enfermedad pulmonar obstructiva crónica [tesis doctoral]. Sevilla: Universidad de Sevilla, 1989.
45. Dean NC, Brown JK, Doherty JJ et al. Oxigen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia. Am Rev Respir Dis 1992; 146: 941-945.
46. Gilbreth EM, Weisman IM. Role of exercise tress testing in preoperative evaluation of patients for lung resection. Clin Chest Med 1994; 15: 389-403.
47. Williams TJ, Patterson GA, McClean PA et al. Maximal exercise testing in single and double lung transplant recipients. Am Rev Respir Dis 1992; 145: 101-105.
48. McGacin CR, Gupta SP, Machardy GJR. Twelve minute walking test for asessing disability in chronic bronchitis. Br Med J 1976; 1: 822-823.
49. Singh SJ, Morgan MDL, Scott SH et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47: 1.019-1.024.
50. Fletcher EC, Miller J, Divine GW et al. Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tension above 60 mmHg. Chest 1987; 92: 604-608.
51. Douglas NJ, Flenley DC. State of the art. Breathing during steep in patients with obstructive lung disease. Am Rev Respir Dis 1990; 141: 1.050-1.070.
52. Tobin MJ. Respiratory muscles in disease. Clin Chest Med 1988; 9: 263-286.
53. Shindoh C, Hida W, Kikuchi Y et al. Oxygen consumption of respiratory muscles in patients with COPD. Chest 1994; 105: 790-797.
54. Rochester DF. The diaphragm in COPD: better than expected, but not good enough. N Engl J Med 1991; 325: 961-962.
55. Rochester DF, Braun NMT. Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 132: 42-47.
56. Ninane V, Gorini M. Adverse effect of hypeinflation on parasternal intercostals. J Appl Physiol 1994; 77: 2.201-2.206.
57. Farkas GA, Roussos C. Diaphragm in emphysematous hamsters: sarcomere adaptability. J Appl Physiol 1983; 54: 1.635-1.640.
58. Tada H, Kato H, Misawa T et al. 31 P-nuclear magnetic resonance evidence of abnormal skeltal muscle metabolism in patients with chronic lung disease and congestive heart failure. Eur Respir J 1992; 5: 163-169.
59. Ninane V, Rypens F, Yernault JC et al. Abdominal muscle use during breathing in patients with chronic airflow obstruction. Am Rev Respir Dis 1992; 146: 16-21.
60. Bellemare F, Grassino A. Force reserve of the diaphragm in patients with chronic obstructive pulmonary disease. J Appl Physiol 1983; 55: 8-15.
61. 2 en pacientes con EPOC. Arch Bronconeumol 1993; 29: 226-228.
62. 2 sobre el diafragma de rata in vitro. Arch Bronconeumol 1994; 30: 445-448.
63. 2 retention in chronic obstructive pulmonary disease [editorial]. Am Rev Respir Dis 1991; 143: 901-903.
64. Martyn JB, Moreno RH, Pare PD et al. Measurement of inspiratory muscle performance with incremental threshold loading. Am Rev Respir Dis 1987; 135: 919-923.
65. Laporta D, Grassino A. Assessment of transdiaphragmatic pressure in humans. J Appl Physiol 1985; 58: 1.469-1.476.
66. Reid MB, Haack KE, Franchek KM et al. Reactive oxygen in skeletal muscle. Intracelular oxidant kinetics and fatigue in vitro. J Appl Physiol 1992; 73: 1.797-1.804.
67. Medical Research Council. Committee on research into chronic bronchitis instructions for use of the questionnaire on respiratory symptoms. Devon: WJ Holman, 1966.
68. Mahler DA, Weinberg DH, Walls CK et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of tow new clinical indexes. Chest 1984; 85: 751-758.
69. Borg G. Psychophysical basis of perceived exertion. Med Sci Sport Exer 1982; 14: 377-381.
70. Guyatt GH, Berman LB, Towsend M et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-778,
71. Jones PW, Quirk FH, Bavesystock CM et al. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1.321-1.327.
72. Guell R, Casan P, Sangenís M et al. Traducción española y validación de un cuestionario de calidad de vida en pacientes con enfermedad pulmonar obstructive crónica. Arch Bronconeumol 1995; 31: 202-210.
73. Johnson RA, Rubin LJ. Non invasive evaluation of right ventricular function. Clin Chest Med 1987; 8: 65-80.
74. Fletcher CM, Pto R, Tinker C et al. The natural history of chronic bronchitis and emphysema. An 8 year study of early chronic obstructive lung disease in working men in London. Nueva York: Oxford University Press, 1976.
75. Carrili AE, Burrows'B, Knudson RJ et al. Longitudinal changes in forced expiratory volume in one second in adults. Effects of smoking and smoking cessation. Am Rev Respir Dis 1987; 135: 794-799.
76. OPeto R, Speizar FE, Cochrane AL et al. The relevance in adults of airflow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Am Rev Respir Dis 1983; 128: 491-500.
77. Freud KM, Belanger AJ, D'Agostino RB et al. The health risks of smoking: the Framingham Study: 34 years of follow-up. Ann Epidemiol 1993; 3: 417-424.
78. Postma DS, Shniter HJ. Prognosis of chronic obstructive pulmonary disease: the Dutch experience. Am Rev Respir Dis 1989; 140 (supl): 100-105.
79. Fiore MC, Smith SS, Jorenby DE et al. Review. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. Jama 1994; 271: 1.940-1.947.
80. Jiménez CA, González de la Vega JM, Escudero C et al. Tabaquismo. Madrid: Manuales SEPAR, Grupo Aula Médica, 1995.
81. Medical Research Council Working Party. Long-term domiciliary oxygen therapy in chronic hipoxic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1: 681-686.
82. Nocturnal Oxygen Therapy Trial Group. Continous or nocturnal oxygen therapy in hipoxemic chronic obstructive pulmonary disease: a clinical trial. Ann Intern Med 1980; 93: 391-398.
83. Normativa para la indicación y empleo de la oxigenoterapia crónica domiciliaria (OCD). Barcelona: Ed. Doyma S.A., 1985.
84. 2 above 60 mmHg. Am Rev Respir Dis 1991; 144: 401-405.
85. Derenne JP, Fleury B, Pariente R. State of the art. Acute respiratory failure of chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 139: 1.006-1.033.
86. Buist AS, Burrows B, Cohen A et al. Guidelines for the approach to the individual with severe hereditary alpha-1-antitrypsin deficiency. An official statement of the American Thoracic Society. Am Rev Respir Dis 1989; 140: 1.494-1.497.
87. Snider GL. Pulmonary disease in alpha-1-antitrypsin deficiency. Ann Intern Med 1989; 111: 967-959.
88. Alpha 1 antitrypsin deficiency. Symposium. Chest 1989; 95: 181-208.
89. Alpha 1 antitrypsin deficiency. Usage of alpha 1 proteinase inhibitor concentrate in replacement therapy. Am J Med 1988; 84 (Supl): 1-90.
90. Dirkens A, Madsen F, Ulrik CS et al. A randomized placebo controlled pilot study of alpha 1 protease inhibitor replacement therapy monitored by daily spirometry [resumen]. Am Rev Respir Dis 1993; 147: 352.
91. Miravitlles M, Vidal R, Torrella M et al. Evaluación del tratamiento sustitutivo del enfisema por déficit de alfa-1-antitripsina. Arch Bronconeumol 1994; 30: 479-484.
92. Grossman RF, Maurer JR. Pulmonary Considerations in transplantation for chronic obstructive pulmonary disease. Clin Chest Med 1990; 11: 195-362.
93. Patterson GA. Lung transplantation for chronic obstructive pulmonary disease. Clin Chest Med 1990: 547-554.
94. Cooper JD, Patterson GA, Grossman R et al. Double lung transplant for advanced chronic obstructive lung disease. Am Rev Respir Dis 1989; 139: 303-307.
95. Mal H, Andreassian B, Pamela F et al. Unilateral lung transplantation in end stage pulmonary emphysema. Am Rev Respir Dis 1989; 140: 797-802.
96. Raffin TA. Double lung transplantation for severe cOPD: reversing the irreversible. Am Rev Respir Dis 1989; 139: 300-301.
97. Ziment I. Pharmacologic therapy of obstructive airway disease. Clin Chest Med 1990; 11: 461-486.
98. Gross NJ. Chronic obstructive pulmonary disease. Currents concepts and therapeutic approaches. Chest 1990 97 (supl): 19-23.
99. Jaeschke R, Guyatt GH, Cook D et al. The effect of increasing doses of beta agonists on airflow in patients with chronic airflow limitation. Respir Med 1993; 87: 433-438.
100. Cazzola M, Santangelo G, Piccolo A et al. Effect of salmeterol and formeterol in patients with chronic obstructive pulmonary disease. Pulm Pharmacol 1994; 7: 103-107.
101. Suppli Urrik CH. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study. Thorax 1995; 50: 750-754.
102. Gross NH, Petty TL, Friedman M et al. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 139: 1.185-1.191.
103. Gross NJ, Skoridin MS. Antiholinergic antimuscarinic bronchodilators. Am Rev Respir Dis 1984; 129: 856-870.
104. Flenley DC. Chronic obstructive pulmonary disease. Dis Month 1988; 12: 543-599.
105. Easton PA, Jadue C, Dhingra S et al. A comparison of the bronchodilating effects of a beta 2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence. N Engl J Med 1986; 315: 735-739.
106. Karpel JF. Bronchodilator responses to anticholinergic and beta adrenergic agents in acutye and stable COPD. Chest 1991; 99: 871-876.
107. Fergurson GT, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med 1993; 328: 1.017-1.022.
108. Gross N, Bankwala Z. Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1987; 136: 1.091-1.094.
109. Bone R. Combivent inhalation aerosol study group. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85 day multicenter trial. Chest 1994; 105: 1.411-1.419.
110. Karpel JP, Kotch A, Zinny M et al. A comparison of inhaled ipatropium, oral theophylline plus inhaled betaagonist, and the combination of all three in patient with COPD. Chest 1994; 105: 1.089-1.094.
111. Bel EH, Zwinderman AH, Timmers MC et al. The protective effect of a beta-2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuly in asthma and chronic obstructive lung disease. Thorax 1991; 46: 9-14.
112. Kesten S, Rebuck AS, Champman KR. Trends in asthma and chronic obstructive pulmonary disease therapy in Canada. J Allergy Clin Immunol 1993; 92: 499-506.
113. Sclar DA, Legg RF, Skaer TL et al. Ipratropium bromide in the management of chronic obstructive pulmonary disease: effect on health service expenditures. Clin Ther 1994; 16: 595-601.
114. Murciano D, Auclair MH, Pariente R et al. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. N Ensl J Med 1989; 320: 1.521-1.525.
115. Jenne JW. What role for theophylinne therapy? Thorax 1994; 49: 97-100.
116. Lamont H, Vander Stracten M, Plauwels R et al. The combined effect of theophylline and terbutaline in patients with chronic obstructive disease. Eur J Respir Dis 1982; 63: 13-22.
117. Martin GE, Hatnett BJS, Berend N et al. Assessment of combined oral theophylline and inhaled beta 2 adrenoceptor agonist bronchodilator therapy. Br J Clin Pharmacol 1978; 5: 45-50.
118. Filuk RB, Earton PA, Anthonisen NR. Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 132: 871-874.
119. Sahn SA. Corticosteroids in chronic bronchitis and pulmonary emphysema. Chest 1978; 73: 871-874.
120. Callahan C, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta analysis. Ann Intern Med 1991; 114: 216-223.
121. Albert RK, Martin TR, Lewis SW. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 1980; 92: 753-758.
122. Renkemar TEJ, Sluiter HJ, Koeter GH et al. A two year prospective study on the effect of inhaled and inhaled plus oral corticosteroids in chronic airflow obstruction [resumen]. Am Rev Respir Dis 1990; 141: 504.
123. Kerstjen HAM, Brand PLP, Hughes MD et al. A comparison of bronchodilator therapy with or withoot inhaled corticosteroids therapy for obstructive airways disease. N Engl J Med 1992; 327: 1.413-1.419.
124. Dompeling E, Van Schayck CP, Van Grunsven PV et al. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. Ann Intern Med 1993; 118: 770-778,
125. Saint S, Bent S, Wittinghoff E et al. Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta analysis. JAMA 1995; 273: 957-960.
126. MacFarlane JT, Finh RG, Ward MD et al. Hospital study of adult community acquired pneumonia. Lancet 1982; 2: 255-258.
127. Fedson DC. Influenza and pneumococcal immunization strategies for physicians. Chest 1987; 91: 436-443.
128. Simberkoff MS, Cross AP, Al Ibrahim M et al. Efficacy of pneumococcal vaccine in high risk patients: results of a Veterans Administrarion Cooperative Study. N Engl J Med 1986; 315: 1.318-1.327.
129. Centers for disease control update: neumococcal polysacharide vaccine usage, United States. MMWR 1984; 33: 273-276-281.
130. Muir JF, Pierson DJ, Petty TL et al. Pulmonary rehabilitation in chronic respiratory insufficiency. 1 to 9. Thorax 1993; 48: 854, 1994; 49: 279-280.
131. Muir JF, Pierson DJ, Petty TL et al. Pulmonary rehabilitation in chronic respiratory insufficiency. 1 to 9. Thorax 1993; 48: 854, 1994; 49: 279-280.
132. Güell, Rous R, Casan Clara P, García Besada JA et al. Número monográfico sobre rehabilitación respiratoria. Arch Bronconeumol 1994; 30: 63-113.
133. Pulmonary Rehabilitation Research NIH Workshop Summary. Am Rev Respir Dis 1994; 49: 825-893.
134. Casabury. Principles and practice of pulmonary rehabilitation. En: Casabury R, Petty TL, editores. Filadelfia: W.B. Saunders Co., 1993.
135. Celli BR. Pulmonary rehabilitation in patients with COPD. Am J Crit Care Med 1995; 152: 861-864.
136. Toshima M, Kaplan M, Ries AL. Experimental evaluation of rehabilitation in chronic obstructive pulmonary disease. Short term effects on excercise endurance and health status. Health Psychol 1990; 9: 237-252.
137. Goldstein RS, Gork EH, Stubbing MA et al. Randomized control trial of respiratory rehabilitation. Lancet 1994; 344: 1.394-1.397.
138. Wykstra PJ, Van Altens R, Kraan J et al. Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home. Eur Respir J 1994; 7: 269-273.
139. Ries AL, Kaplan RM, Limberg TM et al. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstruction pulmonary disease. Ann Intern Med 1995; 122: 823-832.
140. Celli BR, Rassulo J, Make BJ. Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction. N Engl J Med 1986; 314: 1.483-1.490.
141. Criner GJ, Celli BR. Effect of unsupported arm exercise on ventilatory muscle recruitment in patients with severe chronic airflow obstruction. Am Rev Respir Dis 1988; 138: 856-861.
142. Ries AL, Ellis B, Hawkins RW. Upper extremity exercise training in chronic obstructive pulmonary disease. Chest 1988; 93: 688-692.
143. Lake ER, Henderson K, Briffa T et al. Upper limb and lower limb exercise training in patients with chronic airflow obstruction. Chest 1990; 97: 1.077-1.082.
144. Martínez FJ, Vogel PD, Dupont DN et al. Supported arm exercise vs unsupported arm exercise in the rehabilitation of patients with chronic airflow obstruction. Chest 1993; 1.397-1.402.
145. Casabury R, Patessio A, Ioli F et al. Reduction in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung. Am Rev Respir Dis 1991; 143: 9-18.
146. Wasserman K, Sue DY, Casaburi R et al. Selection criteria for exercise training in pulmonary rehabilitation. Eur Respir J 1989 2 (Supl):604-610.
147. Punzal PA, Ries AI, Kaplan RM et al. Maximum intensity exercise training in patients with chronic obstructive pulmonary disease. Chest 1991; 100: 618-623.
148. Donner CF, Howard P. Pulmonary rehabilitation in chronic obstructive pulmonary disease (COPD) with recomendations. Eur Respir J 1992; 5: 226-275.
149. Vijkstra PJ, Ten Vergert EM, Van Altena R et al. Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease. Thorax 1995; 50: 824-828.
150. Levine S, Weiser P, Guillen J. Evaluation of a ventilatory muscle endurance training program in the rehabilitation of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 400-406.
151. Belman MJ, Mittman C. Ventilatory muscle training improves exercise capacity in COPD. Am Rev Respir Dis 1980; 121: 273-280.
152. Clanton TL, Dixon G, Drake J et al. Inspiratory muscle training conditioning using a thresholdloading device. Chest 1985; 87: 62-66.
153. Pardy RL, Reid WD, Belman MJ. Respiratory muscle training. Clin Chest Med 1988; 9: 287-296.
154. Smith K, Cook D, Guyatt GH et al. Respiratory muscle training in chronic airflow limitation: a metaanalysis. Am Rev Respir Dis 1992; 145: 533-539.
155. Belman MJ, Warren C, Botnick et al. Ventilatory load characteristics during ventilatory muscle training. Am J Respir Crit Care Med 1994; 149: 925-991.
156. Bott J, Carrol MP, Conway JH et al. Randomized controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 1993; 341: 1.555-1.557.
157. Mancebo J, Benito S, Nett A. Efecto de la ventilación con presión de soporte con máscara facial en pacientes con insuficiencia respiratoria crónica en descompensación aguda. Med Clin (Bare) 1994; 102: 641-646.
158. Brochard L, Mancebo J, Wysocki M et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333: 817-822.
159. Meduri Gu, Abou-Shala N, Fox RC et al. Noninvasive face mask mechanical ventilation in patients with acute hypercapnic respiratory failure. Chest 1991; 100: 445-454.
160. Sassi Drambon DE, Eakin EG, Ries AL et al. Treatment of dyspnea in COPD. A controlled clinical trial of dyspnea management strategies. Chest 1995; 107: 724-729.
161. Wiedemann HP, Matthay RA. Cor pulmonale in chronic obstructive pulmonary disease. Circulatory Pathophysiology and management. Clin Chest Med 1990; 11: 523-545.
162. Rubin LJ. Vasodilators and pulmonary hypertension where do we go from here? Am Rev Respir Dis 1987; 135: 288-293.
163. Adnot S, Kouyoumdjian C, Defouilloy C. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive disease and pulmonary hypertension. Am Rev Respir Dis 1993; 148: 310-316.
164. Dupuy PM, Shore SA, Drazen JM et al. Bronchodilators action of inhaled nitric oxide in guinnea pigs. J Clin Invest 1992; 90: 421-428.
165. Brain JD. Aerosol and humidity therapy. Am Rev Respir Dis 1980; 122 (Supl): 17-21.
166. Shim Ch, King M, Williams MH. Lack of effects of hydratation on sputum production in chronic bronchitis. Chest 1987; 92: 679-682.
167. Multicenter Study Group. Long-term oral acetylcysteine in chronic beonchitis, a double-blind controlled study. Eur J Respir Dis 1980; 111 Supl: 93-108.
168. Boman G, Backer U, Larsson S et al. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for pulmonary diseases. Eur J Respir Dis 1983; 64: 405-415.
169. Petty TL. The National Mucolytic Study. Results of a randomized, double-blind placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. Chest 1990; 97: 75-83.
170. Izquierdo J, Morera J. Respiratory stimulants and COPD [editorial]. Am Rev Respir Dis 1994; 12: 1.003-1.005.
171. Arnaud F, Bertrand A, Charpin J et al. Long-term almitrine bimesylate treatment in patients with chronic bronchitis and emphysema. A multicenter double blind placebo controlled study. Eur J Respir Dis 1983; 126 Supl: 323-330.
172. Bell RC, Mulling RC, West LG et al. The effect of almitrine bismesylate on hipoxemia in chronic obstructive pulmonary disease. Ann Intern Med 1986; 105: 342-346.
173. Escourron P, Simonneau G, Ausquer JC et al. A single orally administered dose of almitrine improves pulmonary gas exchange during exercise in patients with chronic airflow obstruction. Am Rev Respir Dis 1986; 133: 562-567.
174. Herve P, Musset D, Simonneau G et al. Almitrine decreases the distensibility of the large pulmonary arteries in man. Chest 1989; 96: 572-577.
175. Ferrer M, Alonso J, Antó JM et al. The Spanich version of the St. George's Respiratory Questionnaire (SGRQ): adaptation and preliminary validity. Eur Respir J 1995; 8 (19 supl): 54.
176. Kanford SL, Fiore MC, Jorenby DE et al. Predicting smoking cessation: who will quit with and without the nicotine patch. JAMA 1994; 271: 589-594.
177. Olsen GN. The evolving role of exercise testing prior to lung resection. Chest 1989; 95: 218-225.
178. Bautista A. Factores que inciden en la descompensación de la enfermedad pulmonar obstructive crónica. En: Castillo J, editor. EPOC, perspectives actuales. Madrid: Aula Médica, 1995; 73-87.
179. Jones PW, Bosh TK. Improvement in quality of life in COPD patients treated with sameterol. Am J Respir Crit Care Med 1995; 151: 464.
180. Friedman M. Changing practices in COPD. A new pharmacologic treatment algorithm. Chest 1995; 107: 194-197.
181. Tashkin DP. Multiple dose regimens. Impact on compliance. Chest 1995; 107: 176-182.
182. Montemayor T. Rehabilitación respiratoria en la EPOC. En EPOC, perspectives actuales. Madrid: Aula Médica, 1995; 91-125.
183. 1. JAMA 1994; 272: 1.497-1.505.
184. Siafakas NM et al. ERS Consensus Statement Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1.398-1.420.
185. Celli BR et al. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: 77-120.